In another study from 2022, comprising 565 meningioma specimens, Choudhury and colleagues identified a similar molecular group designated as “immune-enriched”, which was characterized by the presence of lymphatic vessels, increased immune infiltration and HLA expression, as well as a loss of chromosome 22q (NF2) and a gain of chromosome 6p (HLA) as genetic features [26]. Here, NF2 is linked to meningioma.